Modeled Dalbavancin Transmembrane Clearance during Intermittent and Continuous Renal Replacement Therapies

Abstract

Dalbavancin CLtm is dependent on RRT modality, hemodiafilter, and effluent flow. Dalbavancin doses may need to be adjusted depending on RRT parameters.